Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies.
J Neurosurg Spine
; 24(5): 760-8, 2016 May.
Article
em En
| MEDLINE
| ID: mdl-26824587
Palavras-chave
ACDF = anterior cervical discectomy and fusion; AE = adverse event; CTDR = cervical total disc replacement; FDA = Food and Drug Administration; ICER = incremental cost-effectiveness ratio; IDE = investigational device exemption; NIS = Nationwide Inpatient Sample; NMB = net monetary benefit; QALYs = quality-adjusted life years; RCT = randomized controlled trial; SF-36 = 36-Item Short Form Health Survey; WTP = willingness to pay; anterior cervical discectomy and fusion; cervical total disc replacement; cost-effectiveness; single-level degenerative disc disease
Texto completo:
1
Temas:
ECOS
/
Aspectos_gerais
/
Avaliacao_economica
/
Financiamentos_gastos
Bases de dados:
MEDLINE
Assunto principal:
Fusão Vertebral
/
Discotomia
/
Anos de Vida Ajustados por Qualidade de Vida
/
Degeneração do Disco Intervertebral
/
Substituição Total de Disco
Tipo de estudo:
Clinical_trials
/
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Aspecto:
Patient_preference
Limite:
Female
/
Humans
/
Male
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Neurosurg Spine
Assunto da revista:
NEUROCIRURGIA
Ano de publicação:
2016
Tipo de documento:
Article